Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone. (Source: Reuters: Health)
Indivior shares tank after U.S. indictment for illegal marketing
Previous post: New Buprenorphine and Naloxone Sublingual Film Indicated for The Treatment of Opioid Dependence
